Natalie C. Holles - Insider Trading & Ownership

Location
C/O Hyperion Therapeutics, Inc., 2000 Sierra Point Parkway, Suite 400, Brisbane, CA
Summary
The estimated net worth of Natalie C. Holles is at least $750K dollars as of November 7, 2025. Natalie C. Holles is the CEO, Director of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $750K.
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Email me when Natalie C. Holles files a new Ownership 3,4,5 report.

⭐ Subscribe ⭐

Ownership of Natalie C. Holles

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
THRD Third Harmonic Bio, Inc. CEO, Director $750K Aug 11, 2025
ALLK Allakos Inc. Director May 25, 2021
DAWN Day One Biopharmaceuticals, Inc. Director Nov 6, 2025
RUBY Rubius Therapeutics, Inc. Director May 12, 2022

Insider Transactions Reported by Natalie C. Holles:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.